This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindner, S. E.
Right arrow Articles by Sugden, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindner, S. E.
Right arrow Articles by Sugden, B.

 Previous Article  |  Next Article 

Journal of Virology, June 2008, p. 5693-5702, Vol. 82, No. 12
0022-538X/08/$08.00+0     doi:10.1128/JVI.00332-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Affinity of EBNA1 for Its Origin of DNA Synthesis Is a Determinant of the Origin's Replicative Efficiency{triangledown} ,{dagger}

Scott E. Lindner,1,{ddagger} Krisztina Zeller,2 Aloys Schepers,2 and Bill Sugden1*

Department of Cancer Biology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin 53706,1 Department of Vectors, Helmholtz Center Munich, National Research Center for Health and Environment, Marchioninistrasse 25, 81377 Munich, Germany2

Received 15 February 2008/ Accepted 25 March 2008

Epstein-Barr virus (EBV) replicates its genome as a licensed plasmid in latently infected cells. Although replication of this plasmid is essential for EBV latent infection, its synthesis still fails for 16% of the templates in S phase. In order to understand these failures, we sought to determine whether the affinity of the initiator protein (EBNA1) for its binding sites in the origin affects the efficiency of plasmid replication. We have answered this question by using several engineered origins modeled upon the arrangement of EBNA1-binding sites found in DS, the major plasmid origin of EBV. The human TRF2 protein also binds to half-sites in DS and increases EBNA1's affinity for its own sites; we therefore also tested origin efficiency in the presence or absence of these sites. We have found that if TRF2-half-binding sites are present, the efficiency of supporting the initiation of DNA synthesis and of establishing a plasmid bearing that origin directly correlates with the affinity of EBNA1 for that origin. Moreover, the presence of TRF2-half-binding sites also increases the average level of EBNA1 and ORC2 bound to those origins in vivo, as measured by chromatin immunoprecipitation. Lastly, we have created an origin of DNA synthesis from high-affinity EBNA1-binding sites and TRF2-half-binding sites that functions severalfold more efficiently than does DS. This finding indicates that EBV has selected a submaximally efficient origin of DNA synthesis for the latent phase of its life cycle. This enhanced origin could be used practically in human gene vectors to improve their efficiency in therapy and basic research.


* Corresponding author. Mailing address: Room 814, 1400 University Ave., Madison, WI 53706. Phone: (608) 262-1116. Fax: (608) 262-2824. E-mail: sugden{at}oncology.wisc.edu

{triangledown} Published ahead of print on 2 April 2008.

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/.

{ddagger} Present address: Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI 53706.


Journal of Virology, June 2008, p. 5693-5702, Vol. 82, No. 12
0022-538X/08/$08.00+0     doi:10.1128/JVI.00332-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Dresang, L. R., Vereide, D. T., Sugden, B. (2009). Identifying Sites Bound by Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) in the Human Genome: Defining a Position-Weighted Matrix To Predict Sites Bound by EBNA1 in Viral Genomes. J. Virol. 83: 2930-2940 [Abstract] [Full Text]  
  • Zhou, J., Snyder, A. R., Lieberman, P. M. (2009). Epstein-Barr Virus Episome Stability Is Coupled to a Delay in Replication Timing. J. Virol. 83: 2154-2162 [Abstract] [Full Text]